Swine Flu (H1N1) in 12-Year-Olds: Risk, Severity, and Recovery

During the 2009 H1N1 pandemic and subsequent seasons, children aged 5–17 had higher infection rates but lower mortality than young children or adults with comorbidities.

Risk Profile for 12-Year-Olds

• Infection Risk: High (school transmission, no prior immunity).
• Severity: Most cases mild (fever, cough, myalgia, 3–7 days).
• Complications: Pneumonia (viral/bacterial), encephalitis, myocarditis, Reye's syndrome (if aspirin given), exacerbation of asthma/diabetes.
• Mortality: Low overall (~0.01–0.03%), but ↑ with: asthma, neurodevelopmental disorders, immunosuppression, obesity, chronic lung/heart disease.

CDC Data (2009 Pandemic)

• Pediatric deaths: 358 reported (Apr 2009–Apr 2010); 67% had ≥1 high-risk condition.
• Median age of death: 9 years.

Management

• Antivirals (Oseltamivir): Recommended within 48 hrs for high-risk or hospitalized; consider for all children if severe/progressive.
• Supportive: Hydration, antipyretics (NO aspirin), rest.
• Vaccination: Annual flu vaccine includes H1N1 strain. Best prevention.

Warning Signs for ER

• Fast/troubled breathing, bluish lips, dehydration, unresponsiveness, fever with rash, recurrence after improvement.

While generally not deadly for healthy 12-year-olds, swine flu warrants vigilance—especially with comorbidities. Vaccination and early antiviral use are key.